Collecting data for MSTX
. This company stock is not elastic to its hype. The average elasticity to hype of competition is -0.16. Mast Therapeutics Inc is projected not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 13600.0%. The immediate return on the next news is projected to be very small where as daily expected return is now at 0.13%. The volatility of relative hype elasticity to Mast is about 214.85%%. The volatility of related hype on Mast is about 214.85% with expected price after next announcement by competition of 0.33. About
of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.46. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mast Therapeutics Inc recorded
. This company had not issued any dividends in recent years. The firm had
on April 26, 2010. Given the investment horizon of 30 days, the next projected press release will be uncertain.